Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DYNAGITO: Tiotropium + Olodaterol in COPD
NCT02296138Phase 3Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Jan 2015
- Primary completion
- Mar 2017
- Modality
- Small Molecules
- Countries
- 51
01
Overview
A Phase 3 trial of olodaterol in chronic obstructive pulmonary disease (COPD), sponsored by Boehringer Ingelheim. Started Jan 2015; status: completed.
02
Drugs
olodaterol
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT02296138.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02296138.